CalciMedica is trading at $0.73 (5.2%) up today, continuing a rebound following a string of sharp declines over the past week.
- The move appears to be primarily technical and sentiment-driven, as there are no new earnings, FDA decisions, M&A announcements, or major filings reported today.
- Analysts noted that yesterday’s after-hours strength also lacked a clear catalyst, suggesting the current price action is not driven by fundamental news.